Chemical name: 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
Formula: C28H38N6O11S
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

SUHAGRA-25

Description: Suhagra-25 is a pharmaceutical product manufactured by Cipla Pharmaceuticals. It contains Sildenafil as its active substance and is primarily utilized to treat erectile dysfunction (ED) in men. Suhagra-25 is available in the form of tablets, with each tablet containing 25 mg of Sildenafil.

Active Substance: Sildenafil is the active substance in Suhagra-25, belonging to the class of phosphodiesterase type 5 (PDE5) inhibitors. It acts by increasing blood flow to the penis during sexual stimulation, thereby aiding in achieving and maintaining an erection. Sildenafil’s mechanism involves the inhibition of PDE5, leading to the relaxation of smooth muscle cells and vasodilation of penile arteries, facilitating erectile function.

Manufacturer: Suhagra-25 is manufactured by Cipla Pharmaceuticals, a renowned pharmaceutical company known for its commitment to producing high-quality medications. Cipla adheres to strict manufacturing standards to ensure the safety, efficacy, and consistency of its products.

Formulation: Each package of Suhagra-25 typically contains 4 tablets, each tablet containing 25 mg of Sildenafil. This formulation provides an adequate supply for multiple doses and allows for convenient use as needed.

Usage and Dosage: Suhagra-25 tablets are taken orally, usually about 30 minutes to 1 hour before sexual activity. The recommended starting dose is 25 mg, although this may be adjusted based on individual response and tolerance. Depending on effectiveness and tolerability, the dosage may be increased to 50 mg or decreased to 25 mg. It is essential not to exceed one tablet per day.

Storage Conditions: Suhagra-25 tablets should be stored in a cool, dry place at room temperature, away from direct sunlight and moisture. It is crucial to keep them out of reach of children and pets to prevent accidental ingestion. Proper storage helps maintain the stability and efficacy of the medication.

Mechanism of Action: Sildenafil in Suhagra-25 acts by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which degrades cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. By inhibiting PDE5, Sildenafil prolongs the action of cGMP, promoting smooth muscle relaxation and increased blood flow to the penis, resulting in erections suitable for sexual activity.